Physician profile
Mack P Hendrix
NPI 1750546701
$2,177.61
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,585 · 2020: $126 · 2021: $42.01 · 2022: $117 · 2023: $269 · 2024: $38.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,370.19 | 2019-2024 | Angiojet Ultra 5000a |
| Inari Medical, INC. | $272.10 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $159.67 | 2019-2023 | Cook |
| Avenu Medical INC. | $122.77 | 2019 | |
| Medtronic Vascular, INC. | $105.21 | 2019-2020 | |
| Medtronic, INC. | $25.45 | 2021-2022 | |
| Angiodynamics, INC. | $21.96 | 2024 | Alphavac |
| Penumbra, INC. | $18.60 | 2020 | |
| Teleflex LLC | $18.10 | 2022 | |
| Abbott Laboratories | $18.10 | 2023 | Jeti Peripheral Catheter |
| Covidien Lp | $16.42 | 2019 | |
| Cardiva Medical, INC. | $15.23 | 2023 | Cardiva Vascade 6/7f Vcs |
| Medtronic USA, INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mack Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.